"Zku\u0161enosti s chelata\u010Dn\u00ED l\u00E9\u010Dbou u myelodysplastick\u00E9ho syndromu" . "Experiences with chelation therapy in myelodysplastic syndrome."@en . "3" . "Experiences with chelation therapy in myelodysplastic syndrome."@en . "1"^^ . . "N" . . "RIV/00064165:_____/09:5851" . . "1801-1209" . . . "CZ - \u010Cesk\u00E1 republika" . "Myelodysplastick\u00FD syndrom (MDS) je klon\u00E1ln\u00ED onemocn\u011Bn\u00ED hemopoetick\u00E9 tk\u00E1n\u011B. Zahrnuje heterogenn\u00ED skupinu onemocn\u011Bn\u00ED, pro n\u011B\u017E je charakteristick\u00E1 diskrepance mezi bohatou krvetvorbou a perifern\u00ED pancytopeni\u00ED jako n\u00E1sledek inefektivn\u00ED hemopoezy s klinick\u00FDmi projevy anemie, infekce a krv\u00E1cen\u00EDm." . . "RIV/00064165:_____/09:5851!RIV10-MZ0-00064165" . "Zku\u0161enosti s chelata\u010Dn\u00ED l\u00E9\u010Dbou u myelodysplastick\u00E9ho syndromu"@cs . "Myelodysplastic syndrome (MDS) is clonal disease of hemopoietic tissue. It includes heterogeneous group of diseases with characteristics discrepancy between cellular bone marrow and peripheral pancytopenia and risk od transformation to acute leukemia."@en . "5"^^ . "Myelodysplastick\u00FD syndrom (MDS) je klon\u00E1ln\u00ED onemocn\u011Bn\u00ED hemopoetick\u00E9 tk\u00E1n\u011B. Zahrnuje heterogenn\u00ED skupinu onemocn\u011Bn\u00ED, pro n\u011B\u017E je charakteristick\u00E1 diskrepance mezi bohatou krvetvorbou a perifern\u00ED pancytopeni\u00ED jako n\u00E1sledek inefektivn\u00ED hemopoezy s klinick\u00FDmi projevy anemie, infekce a krv\u00E1cen\u00EDm."@cs . "Jon\u00E1\u0161ov\u00E1, Anna" . . . "chelation therapy; myelodysplastic syndrome; iron overload"@en . "[AC4CD11E591E]" . . "Zku\u0161enosti s chelata\u010Dn\u00ED l\u00E9\u010Dbou u myelodysplastick\u00E9ho syndromu"@cs . "Zku\u0161enosti s chelata\u010Dn\u00ED l\u00E9\u010Dbou u myelodysplastick\u00E9ho syndromu" . . "353156" . "1"^^ . . "2009" . . . "Farmakoterapie" . .